Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

NGM BIOPHARMACEUTICALS INC (NGM)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-K10-KS-1
Revenues   [+]55.377.987.4103.5108.777.182.1
            Revenue growth  -29.0%-10.8%-15.6%-4.7%40.9%-6.0% 
Cost of goods sold  0.00.00.00.00.00.094.0
Gross profit  55.377.987.4103.5108.777.1-11.8
            Gross margin  100.1%100.0%100.0%100.0%100.0%100.0%-14.4%
Selling, general and administrative   [+]40.536.927.223.617.314.811.8
Research and development  181.1161.7164.0129.395.779.7 
Other operating expenses        -15.3
EBITDA   [+]-162.2-114.6-97.3-41.72.9-11.0-4.8
            EBITDA margin  -293.3%-147.1%-111.3%-40.3%2.7%-14.2%-5.9%
Depreciation and amortization  4.06.16.67.67.26.43.5
EBIT   [+]-166.2-120.7-103.8-49.3-4.3-17.4-8.4
            EBIT margin  -300.6%-154.9%-118.8%-47.7%-4.0%-22.6%-10.2%
Interest income  3.70.41.96.73.62.41.8
Other income (expense), net  -0.1-0.1-0.6-0.10.2-0.20.1
Pre-tax income  -162.7-120.3-102.5-42.8-0.5-15.2-6.4
Income taxes  0.00.00.00.00.0-1.10.5
            Tax rate  0.0%0.0%0.0%0.0%0.0%7.0% 
Net income  -162.7-120.3-102.5-42.8-0.5-14.2-6.9
            Net margin  -294.2%-154.5%-117.3%-41.3%-0.5%-18.4%-8.4%
   
Basic EPS   [+]($2.03)($1.56)($1.50)($0.85)($0.08)($2.37)($0.63)
Diluted EPS   [+]($2.03)($1.56)($1.50)($0.85)($0.08)($2.37)($0.63)
   
Shares outstanding (basic)   [+]80.077.168.550.36.46.011.1
Shares outstanding (diluted)   [+]80.077.168.550.36.46.011.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy